CN103638242A - Traditional Chinese medicine composition for treating prostatic hyperplasia - Google Patents
Traditional Chinese medicine composition for treating prostatic hyperplasia Download PDFInfo
- Publication number
- CN103638242A CN103638242A CN201310532799.4A CN201310532799A CN103638242A CN 103638242 A CN103638242 A CN 103638242A CN 201310532799 A CN201310532799 A CN 201310532799A CN 103638242 A CN103638242 A CN 103638242A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicine composition for treating prostatic hyperplasia, which is composed of raw materials by weight: 8-10 parts of pseudo-ginseng, 2-4 parts of oyster, 3-5 parts of cyathula roots, 1-3 parts of oriental waterplantain rhizomes, 3-5 parts of morinda roots, 2-3 parts of cuscuta seeds, 5-6 parts of astragalus roots, 9-11 parts of myrrh, 4-6 parts of fried large-headed atractylodes, 2-4 parts of areca peels, 1-2 parts of rhaponticum, 6-8 parts of licorice, 3-5 parts of vaccaria seeds, 5-7 parts of dandelion, 2-4 parts of human placenta, 1-3 parts of oldenlandia, 2-4 parts of kalimeris, 2-4 parts of common sage herbs, 1-2 parts of arrowhead leaves and 1-2 parts of agrimony. The invention provides a compatibility of traditional Chinese medicines, which has efficacies for nourishing yin and blood, adjusting and nourishing liver and kidney, relaxing vein and activating blood, reducing heat and treating stranguria; The present invention can treat prostatic hyperplasia with good curative effect and fast effectiveness without any toxic and side effects.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of prostate hyperplasia, belong to the field of Chinese medicines.
Background technology
Prostate hyperplasia is that kind of prostate obviously increases and unhealthful commonly encountered diseases, symptom mainly contains frequent micturition, dysuria and urinary retention, if do not treated, will be developed to uremia, the Chinese medicine of specially controlling at present prostate hyperplasia is not a lot, as Qianliekangshu Capsule, blue classical pollen capsule etc., these medicines can alleviate the symptom of prostatic hyperplasia, but can not eradicate focus completely, curative effect is not ten obvious.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition for the treatment of prostate hyperplasia.
The present invention adopts following technical scheme:
The Chinese medicine composition for the treatment of prostate hyperplasia, the weight portion of its constitutive material is: Radix Notoginseng 8-10, Concha Ostreae 2-4, Radix Cyathulae 3-5, Rhizoma Alismatis 1-3, Radix Morindae Officinalis 3-5, Semen Cuscutae 2-3, Radix Astragali 5-6, Myrrha 9-11, Rhizoma Atractylodis Macrocephalae (parched) 4-6, Pericarpium Arecae 2-4, Radix Rhapontici 1-2, Radix Glycyrrhizae 6-8, Semen Vaccariae 3-5, Herba Taraxaci 5-7, Placenta Hominis 2-4, Herba Hedyotidis Diffusae 1-3, Herba Kalimeridis 2-4, favus grass 2-4, Folium sagittariae sagittifoliae 1-2 and Herba Lespedezae Cuneatae 1-2.
The Chinese medicine composition for the treatment of prostate hyperplasia, the weight portion of its constitutive material is: Radix Notoginseng 9, Concha Ostreae 3, Radix Cyathulae 4, Rhizoma Alismatis 2, Radix Morindae Officinalis 4, Semen Cuscutae 2.5, the Radix Astragali 5.5, Myrrha 10, Rhizoma Atractylodis Macrocephalae (parched) 5, Pericarpium Arecae 3, Radix Rhapontici 1.5, Radix Glycyrrhizae 7, Semen Vaccariae 4, Herba Taraxaci 6, Placenta Hominis 3, Herba Hedyotidis Diffusae 2, Herba Kalimeridis 3, favus's grass 3, Folium sagittariae sagittifoliae 1.5 and Herba Lespedezae Cuneatae 1.5.
By the weight portion of constitutive material, take each raw material, decoct 20-30 minute, then boil with high heat and use again slow fire instead and decoct 10-15 minute, remove medicinal residues, get decoction, potion on the one, potion is taken at twice, a month course for the treatment of.
Beneficial effect of the present invention:
The all medicine compatibilities of Chinese medicine of the present invention, have nourishing YIN and benefiting blood, adjusting and reinforcing liver and kidney, and dredging collateral is invigorated blood circulation, and treating stranguria effect expels the heat-evil; Treatment prostate hyperplasia good effect, instant effect, without any side effects.
The specific embodiment
Embodiment 1: the Chinese medicine composition for the treatment of prostate hyperplasia, the weight portion of its constitutive material (g) is: Radix Notoginseng 9, Concha Ostreae 3, Radix Cyathulae 4, Rhizoma Alismatis 2, Radix Morindae Officinalis 4, Semen Cuscutae 2.5, the Radix Astragali 5.5, Myrrha 10, Rhizoma Atractylodis Macrocephalae (parched) 5, Pericarpium Arecae 3, Radix Rhapontici 1.5, Radix Glycyrrhizae 7, Semen Vaccariae 4, Herba Taraxaci 6, Placenta Hominis 3, Herba Hedyotidis Diffusae 2, Herba Kalimeridis 3, favus's grass 3, Folium sagittariae sagittifoliae 1.5 and Herba Lespedezae Cuneatae 1.5.
By the weight portion of constitutive material, take each raw material, decoct 20-30 minute, then boil with high heat and use again slow fire instead and decoct 10-15 minute, remove medicinal residues, get decoction, potion on the one, potion is taken at twice, a month course for the treatment of.
Model case:
Case 1: week certain, man, 65 years old, suffers from prostate hyperplasia, dysuria, urine is waited for, urinates line thin, dribbling, intravenous pharmacy and topical therapeutic, effect inequality, take Chinese medicine composition of the present invention, every day potion, potion is taken at twice, take after the course for the treatment of, urine is waited for, the thin symptom of urine line is clearly better, and continues to take after the course for the treatment of, without any ill symptoms, recovery from illness, so far not recurrence.
Case 2: Zhu, man, 62 years old, suffer from prostate hyperplasia, with symptoms such as frequent micturition, urgent micturition, urine waits, get up night often, hospitalization, the state of an illness has no improvement, takes Chinese medicine composition of the present invention, every day potion, potion is taken at twice, takes after 20 doses, frequent micturition, urgent micturition, urine wait for that symptom is clearly better, continue to take after two courses for the treatment of recovery from illness, so far not recurrence.
Case 3: relax certain, man, 57 years old, long-term frequent micturition, urgent micturition, urine were waited for, the prostate B of hospital is super to be shown: prostate 5.2cm * 4.6cm * 4.2cm, take Chinese medicine composition of the present invention, every day potion, potion is taken at twice, takes after two courses for the treatment of, without any ill symptoms.
Claims (2)
1. treat a Chinese medicine composition for prostate hyperplasia, it is characterized in that the weight portion of its constitutive material is: Radix Notoginseng 8-10, Concha Ostreae 2-4, Radix Cyathulae 3-5, Rhizoma Alismatis 1-3, Radix Morindae Officinalis 3-5, Semen Cuscutae 2-3, Radix Astragali 5-6, Myrrha 9-11, Rhizoma Atractylodis Macrocephalae (parched) 4-6, Pericarpium Arecae 2-4, Radix Rhapontici 1-2, Radix Glycyrrhizae 6-8, Semen Vaccariae 3-5, Herba Taraxaci 5-7, Placenta Hominis 2-4, Herba Hedyotidis Diffusae 1-3, Herba Kalimeridis 2-4, favus grass 2-4, Folium sagittariae sagittifoliae 1-2 and Herba Lespedezae Cuneatae 1-2.
2. the Chinese medicine composition for the treatment of prostate hyperplasia according to claim 1, is characterized in that the weight portion of its constitutive material is: Radix Notoginseng 9, Concha Ostreae 3, Radix Cyathulae 4, Rhizoma Alismatis 2, Radix Morindae Officinalis 4, Semen Cuscutae 2.5, the Radix Astragali 5.5, Myrrha 10, Rhizoma Atractylodis Macrocephalae (parched) 5, Pericarpium Arecae 3, Radix Rhapontici 1.5, Radix Glycyrrhizae 7, Semen Vaccariae 4, Herba Taraxaci 6, Placenta Hominis 3, Herba Hedyotidis Diffusae 2, Herba Kalimeridis 3, favus's grass 3, Folium sagittariae sagittifoliae 1.5 and Herba Lespedezae Cuneatae 1.5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310532799.4A CN103638242A (en) | 2013-11-04 | 2013-11-04 | Traditional Chinese medicine composition for treating prostatic hyperplasia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310532799.4A CN103638242A (en) | 2013-11-04 | 2013-11-04 | Traditional Chinese medicine composition for treating prostatic hyperplasia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103638242A true CN103638242A (en) | 2014-03-19 |
Family
ID=50243614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310532799.4A Pending CN103638242A (en) | 2013-11-04 | 2013-11-04 | Traditional Chinese medicine composition for treating prostatic hyperplasia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103638242A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111465403A (en) * | 2017-12-06 | 2020-07-28 | 赫利世弥斯株式会社 | Herbal composition for preventing or treating prostatic hypertrophy |
-
2013
- 2013-11-04 CN CN201310532799.4A patent/CN103638242A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111465403A (en) * | 2017-12-06 | 2020-07-28 | 赫利世弥斯株式会社 | Herbal composition for preventing or treating prostatic hypertrophy |
EP3721891A4 (en) * | 2017-12-06 | 2021-06-09 | Helixmith Co., Ltd | Herbal composition for preventing or treating benign prostatic hyperplasia disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101129620A (en) | Traditional Chinese medicine for treating nasosinusitis headache | |
CN103316295B (en) | Traditional Chinese composition for treating rheumatic arthritis | |
CN103316298B (en) | Traditional Chinese composition for treating arthralgia | |
CN103212021A (en) | Traditional Chinese medicine composition used for treating chloasma | |
CN101152494A (en) | Traditional Chinese medicine for treating acute appendicitis | |
CN104998202A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
CN102552729B (en) | Medicament for treating mesangial proliferative glomerulonephritis | |
CN101623413A (en) | Chinese medicinal composition for treating women mastitis | |
CN101085088A (en) | Traditional Chinese medicine formula for treating prostatic hyperplasia | |
CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
CN103638242A (en) | Traditional Chinese medicine composition for treating prostatic hyperplasia | |
CN104644857A (en) | Traditional Chinese medicine formula for treating acnes | |
CN102579678B (en) | Medicinal composition for treating vitligo | |
CN104324280A (en) | Traditional Chinese medicine composition for treating nasopharynx cancer and preparation method of traditional Chinese medicine composition | |
CN101152293A (en) | Traditional Chinese medicine for treating dacryocystitis of liver rheumatic fever rise | |
CN104587385A (en) | Traditional Chinese medicine composition for treating blood stasis condensation type rosacea | |
CN102784212A (en) | Chinese medicine composition for treating arthralgia-synadrome | |
CN104027430A (en) | Traditional Chinese medicine composition for treating blood stasis type uterine myoma | |
CN103446535A (en) | Miao ethnomedicine for treating coronary heart disease | |
CN101152300A (en) | Traditional Chinese medicine for treating stasis accumulation intestinal obstruction | |
CN1175874C (en) | Medicine made of chuan-xing rhizome for treating thromboangitis obliterans and its presciption | |
CN101152410A (en) | Traditional Chinese medicine for treating alopecia | |
CN101002853A (en) | Oral medicine for treating cephalagra type hemidrosis | |
CN105233103A (en) | Traditional Chinese medicine decoction for treating urinary tract infection | |
CN105749243A (en) | Traditional Chinese medicine for treating coolness diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140319 |